Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy

Masakuni Noguchi, Masashi Inokuchi, Zen Yo

Journal of Surgical Oncology · 2009 · 65 citations · 26 references

Concepts

Abstract

BACKGROUND: The optimal site for injection of mapping tracers is controversial in sentinel lymph node (SLN) biopsy for breast cancer. We evaluated whether a combination of peritumoral (PT) injection and subareolar (SA) injection can improve the identification rate of SLN biopsy and decrease the false-negative rate. METHODS: Two hundred one patients underwent SLN biopsy with PT injection of radioisotope and SA injection of blue dye. RESULTS: The overall identification rate for blue and/or hot lymph nodes was 99.5%; the identification rate of blue-dyed lymph nodes was 98.0% and that of hot lymph nodes was 97.0%. However, no concordance between the hot node and the blue node was found in 17 patients (8.5%). Among SLN-positive 51 patients, 4 patients had blue-only positive SLN and 7 had hot-only positive SLN. Consequently, the false-negative rates were at least 7.8% for PT injection and 13.7% for SA injection, while axillary lymph node dissection was not performed in SLN-negative patients. However, a combination of both injections significantly decreased the false-negative rate. CONCLUSIONS: The success of SLN mapping is optimized not only by using dye and isotope in combination but also by using PT and SA injections in combination.

References

26